Solid Biosciences Daily News Today

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and OKYO Pharma (NASDAQ:OKYO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Analyst Ratings This is a summary of […]

Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Analysts at HC Wainwright reduced their Q2 2024 EPS estimates for Solid Biosciences in a research note issued to investors on Monday, May 20th. HC Wainwright analyst A. He now anticipates that the company will post earnings per share of ($0.72) for the quarter, down from their […]

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have earned a consensus recommendation of “Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued a report on […]

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have been given a consensus recommendation of “Buy” by the six analysts that are currently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued a report on […]

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Century Therapeutics (NASDAQ:IPSC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations. Earnings and Valuation This table compares Solid […]

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Ambrx Biopharma (NYSE:AMAM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Profitability This table compares Solid Biosciences and […]

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have received a consensus rating of “Buy” from the six research firms that are covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock […]

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Immunovant (NASDAQ:IMVT – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability. Profitability This table compares Solid Biosciences and Immunovant’s net […]

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) CFO Kevin Tan sold 3,935 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $8.20, for a total value of $32,267.00. Following the sale, the chief financial officer now directly owns 9,308 shares in the […]

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) COO David T. Howton sold 5,367 shares of Solid Biosciences stock in a transaction on Monday, December 4th. The stock was sold at an average price of $2.78, for a total value of $14,920.26. Following the sale, the chief operating officer now owns 7,684 shares in the […]